Communication
ChemComm
The authors acknowledge the financial support from NNSFC
(21877013 and 21671043) and the National Key R&D Program of
China (2017YFA0205100).
Conflicts of interest
There are no conflicts to declare.
References
1 A. Ammari, A. Bloch-Zupan and P. Ashley, Caries Res., 2003, 37,
85–92.
2 W. M. Edmunds and P. L. Smedley, in Essentials of Medical Geology:
Revised Edition, ed. O. Selinus, Springer Netherlands, Dordrecht,
2013, pp. 311–336, DOI: 10.1007/978-94-007-4375-5_13.
3 J. A. Cury and L. M. A. Tenuta, Adv. Dent. Res., 2008, 20, 13–16.
4 H.-C. Flemming, T. R. Neu and D. J. Wozniak, J. Bacteriol., 2007, 189,
7945–7947.
5 D. L. Ozsvath, Rev. Environ. Sci. Bio/Technol., 2009, 8, 59–79.
6 Z. Wang, G. Ma and X. Y. Liu, J. Phys. Chem. B, 2009, 113, 16393–16399.
7 D. Browne, H. Whelton and D. O’Mullane, J. Dent., 2005, 33,
177–186.
8 X. Xiong, J. Liu, W. He, T. Xia, P. He, X. Chen, K. Yang and A. Wang,
Environ. Res., 2007, 103, 112–116.
9 L. Gai, J. Mack, H. Lu, T. Nyokong, Z. Li, N. Kobayashi and Z. Shen,
Coord. Chem. Rev., 2015, 285, 24–51.
Fig. 3 CLSM images of human in situ plaque biofilms upon PDT treatment.
(a1 and a2) Without any treatment as control; (b1 and b2) treated only with free
FD-F3 (50 mg mLÀ1) for 30 min; (c1 and c2) with NaF (50 mg mLÀ1) for 60 min;
(d1 and d2) with FD-F3 (50 mg mLÀ1) for 30 min and then NaF (50 mg mLÀ1) for
60 min; (e1 and e2) only with light (100 mW cmÀ2) for 5 min; (f1 and f2) with
FD-F3 (50 mg mLÀ1) for 30 min then NaF (50 mg mLÀ1) for 60 min and then light
(100 mW cmÀ2) for 5 min. (a1, b1, c1, d1, e1, and f1) are green channels for
SYTOs 9 probe staining (lex = 488 nm, lem = 500–550 nm); (a2, b2, c2, d2, e2,
and f2) are red channels for propidium iodide probe staining (lex = 488 nm,
10 Y. Zhou, J. F. Zhang and J. Yoon, Chem. Rev., 2014, 114, 5511–5571.
11 J. Xu, S. Sun, Q. Li, Y. Yue, Y. Li and S. Shao, Anal. Chim. Acta, 2014,
849, 36–42.
lem = 600–650 nm).
12 S. Y. Kim, J. Park, M. Koh, S. B. Park and J.-I. Hong, Chem. Commun.,
2009, 4735–4737.
13 J.-T. Yeh, P. Venkatesan and S.-P. Wu, New J. Chem., 2014, 38,
6198–6204.
14 B. Zhu, F. Yuan, R. Li, Y. Li, Q. Wei, Z. Ma, B. Du and X. Zhang,
Chem. Commun., 2011, 47, 7098–7100.
15 C.-Q. Zhu, J.-L. Chen, H. Zheng, Y.-Q. Wu and J.-G. Xu, Anal. Chim.
Acta, 2005, 539, 311–316.
when treated with free FD-F3 (Fig. 3b1 and b2), NaF (Fig. 3c1
and c2), FD-F3 + NaF (Fig. 3d1 and d2) or light (Fig. 3e1 and e2).
However, the proportion of dead bacteria increased by 28%
(Fig. S13, ESI†) when treated with FD-F3 (50 mg mLÀ1, 30 min),
followed by NaF (50 mg mLÀ1) for 60 min and then a laser
16 Z. Wu and X. Tang, Anal. Chem., 2015, 87, 8613–8617.
(100 mW cmÀ2) for 5 min (Fig. 3f1 and f2), indicating that 17 B. Ke, W. Chen, N. Ni, Y. Cheng, C. Dai, H. Dinh and B. Wang, Chem.
FD-F3 could be used as a FÀ regulated prodrug for aPDT in
Commun., 2013, 49, 2494–2496.
18 L. Li, Y. Ji and X. Tang, Anal. Chem., 2014, 86, 10006–10009.
naturally grown human plaque biofilms.
´
19 C. Padie and K. Zeitler, New J. Chem., 2011, 35, 994–997.
In summary, a series of novel fluorescent probes were 20 N. Busschaert, C. Caltagirone, W. Van Rossom and P. A. Gale, Chem.
designed and synthesized for sensing FÀ and performing FÀ
activated aPDT, based on a new platform containing an MB
Rev., 2015, 115, 8038–8155.
21 G. Feng, L. Geng, T. Wang, J. Li, X. Yu, Y. Wang, Y. Li and D. Xie,
J. Lumin., 2015, 167, 65–70.
derivative as the fluorophore. These probes are easily synthe- 22 L. Geng, G. Feng, S. Wang, X. Yu, Z. Xu, X. Zhen and T. Wang,
sized and show high selectivity toward FÀ in an aqueous
solution. Among them, the optimal one, FD-F3, exhibits a
J. Fluorine Chem., 2015, 170, 24–28.
23 R. Li, S. Wang, Q. Li, H. Lan, S. Xiao, Y. Li, R. Tan and T. Yi, Dyes
Pigm., 2017, 137, 111–116.
dramatic increase of NIR fluorescence and red absorption in 24 X. Yu, D. Xie, Y. Li, L. Geng, J. Ren, T. Wang and X. Pang, Sens.
the presence of FÀ, which can be detected by the naked-eye.
Actuators, B, 2017, 251, 828–835.
25 T. H. Kim and T. M. Swager, Angew. Chem., Int. Ed., 2003, 42,
FD-F3 can distinguish FÀ from NaF and SMFP with a low
4803–4806.
detection limit and can be applied to determine the FÀ content 26 F. Cieplik, D. Deng, W. Crielaard, W. Buchalla, E. Hellwig, A. Al-
of toothpastes prepared using different FÀ sources. Moreover,
FD-F3 can distinguish between non-fluoride and fluoride tooth-
Ahmad and T. Maisch, Crit. Rev. Microbiol., 2018, 44, 571–589.
27 S. Rajesh, E. Koshi, K. Philip and A. Mohan, J. Indian Soc. Period-
ontol., 2011, 15, 323–327.
pastes by visualizing fluoride uptake into naturally grown 28 F. Xue, P. Wei, X. Ge, Y. Zhong, C. Cao, D. Yu and T. Yi, Dyes Pigm.,
2018, 156, 285–290.
29 P. Wei, W. Yuan, F. Xue, W. Zhou, R. Li, D. Zhang and T. Yi, Chem.
human plaque biofilms. In addition, FD-F3 could be used
as a FÀ regulated prodrug for antimicrobial photodynamic
Sci., 2018, 9, 495–501.
therapy. These fluoride activated probes thus provide a practical 30 G. Wei, J. Yin, X. Ma, S. Yu, D. Wei and Y. Du, Anal. Chim. Acta, 2011,
platform for monitoring FÀ in biofilms, studying the physiological
703, 219–225.
31 F. Zheng, F. Zeng, C. Yu, X. Hou and S. Wu, Chem. – Eur. J., 2013, 19,
function of FÀ in biological systems and designing a FÀ regulated
936–942.
prodrug for antimicrobial photodynamic therapy.
32 S. T. SebaSTian and S. SiDDanna, J. Clin. Diagn. Res., 2015, 9, ZC09.
13118 | Chem. Commun., 2018, 54, 13115--13118
This journal is ©The Royal Society of Chemistry 2018